SCHEMBL696680

SCHEMBL696680

O=C(CBr)c1[c]cccc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 12/20 0.48
PTPN1 P18031 7/20 0.48
HPGDS O60760 1/20 0.35
CPA1 P15085 1/20 0.33
CES1 P23141 2/20 0.32
CES2 O00748 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7666645 0.81 TDP1 (0.33) GSK3BPTPN1CES1CES2KDM4E
SCHEMBL11257239 0.81 CES1 (0.33) GSK3BPTPN1CES1CES2KDM4E
SCHEMBL989057 0.79 SMN1; SMN2 (0.42) CES1CES2KDM4EMEN1CYP3A4
SCHEMBL7516064 0.79 ALDH1A1 (0.48) GSK3BCES1CES2KDM4EMEN1
SCHEMBL8407064 0.78 L3MBTL1 (0.50) CES1MEN1MAPTKMT2ATDP1
SCHEMBL3268222 0.78 MAPK1 (0.40) GSK3BPTPN1CES1CES2KDM4E
SCHEMBL3248948 0.78 CES1 (0.50) CES1CES2MEN1MAPTHPGD
SCHEMBL1714625 0.76 PAM (0.32) CES1CES2KDM4EMEN1CYP3A4
SCHEMBL2332592 0.76 HPGD (0.46) CES1CES2CYP3A4MAPTHPGD
SCHEMBL1727779 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421855-A1 DIARYL ETHERS Tibotec Pharmaceuticals (IE) 2012-02-29 EP disclosed
WO-2010122162-A1 DIARYL ETHERS TIBOTEC PHARMACEUTICALS (IE) 2010-10-28 WO disclosed
US-7049445-B2 Bicyclic compounds ASAHI KASEI PHARMA CORPORATION (JP) 2006-05-23 US disclosed
US-6861444-B2 Bicyclic compounds ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-01 US disclosed
US-4290943-A Method of preparing polypeptides MAX-PLANK-GESELLSCHAFT (DE) 1981-09-22 US disclosed
US-4290943-A Method of preparing polypeptides MAX-PLANK-GESELLSCHAFT (DE) 1981-09-22 US disclosed